[Successful use of allogeneic stem cell transplantation for treatment-refractory mycosis fungoides].
Mycosis fungoides is the most common type of cutaneous T-cell lymphoma and characterized by a chronic progressive course spanning decades. The choice of treatment options should be tailored to the stage depending on the extent and aggressiveness of the disease and taking the individual situation of the patient into consideration. Long-term complete remissions can only be achieved in the early phase of the disease, while there is no therapy that results in a cure or long-term remission in advanced stages. In young patients with a treatment-refractory course of mycosis fungoides, allogeneic stem cell transplantation represents an important alternative option to manage the disease since complete clinical remission can be obtained even in advanced stages.
Hoff
N P
NP
Hautklinik des Universitätsklinikums Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Deutschland.
Groffik
A
A
Mota
R
R
Pippirs
U
U
Hengge
U R
UR
Kobbe
G
G
Homey
B
B
Bruch-Gerharz
D
D
D006801:Humans; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000473:pathology* / Q000601:surgery*; D033581:Stem Cell Transplantation / Q000379:methods*; D017211:Treatment Failure; D016896:Treatment Outcome
N Engl J Med. 2004 May 6;350(19):1978-88
15128898
Blood. 1991 Feb 1;77(3):649-53
1991174
Recent Pat Anticancer Drug Discov. 2006 Jan;1(1):23-38
18221024
Lancet. 2008 Mar 15;371(9616):945-57
18342689
Arch Dermatol. 2002 Oct;138(10):1359-65
12374543
J Am Acad Dermatol. 2008 Apr;58(4):645-9
18258335